Name: Levonorgestrel Imp. G (EP)
SKU: ACI-121007
Availability: InStock

Catalogue No.

ACI-121007

Product Description

Additional information

Additional information

Appearance

White Powder

Recently Viewed

RAC-LINAGLIPTIN (25 mg) (8-[3-Aminopiperidin-1-yl]-7-(but-2-yn-1-yl)-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]-3,7-dihydro-1H-purine-2,6-dione )
Catalogue No.
1A19830
CAS No.
1383917-84-7
Molecular Formula
C₂₅H₂₈N₈O₂
Product Type
Pharmaceutical Analytical Impurities
View Details
RAC-LINAGLIPTIN PIPERIDINYLAMINE (25 mg) (7-(2-Butyn-1-yl)-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-8-(3-piperidinylamino)-3,7-dihydro-1H-purine-2,6-dione )
Catalogue No.
1A19860
CAS No.
2408969-15-1
Molecular Formula
C₂₅H₂₈N₈O₂
Product Type
Pharmaceutical Analytical Impurities
View Details
N-FORMYL SITAGLIPTIN (25 mg) ((R)-N-(4-Oxo-4-{3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl}-1-(2,4,5-trifluorophenyl)butan-2-yl)formamide )
Catalogue No.
1A20240
CAS No.
3112735-79-9
Molecular Formula
C₁₇H₁₅F₆N₅O₂
Product Type
Pharmaceutical Analytical Impurities
View Details
N-DEMETHYL EDOXABAN (25 mg) (N¹-(5-Chloropyridin-2-yl)-N²-((1S,2R,4S)-4-(dimethylcarbamoyl)-2-(4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine-2-carboxamido)cyclohexyl)oxalamide )
Catalogue No.
1A19770
CAS No.
778571-11-2
Molecular Formula
C₂₃H₂₈ClN₇O₄S
Product Type
Pharmaceutical Analytical Impurities
View Details
DASATINIB CARBOXYLIC ACID (25 mg) ({4-[6-({5-[(2-Chloro-6-methylphenyl)carbamoyl]-1,3-thiazol-2-yl}amino)-2-methyl-4-pyrimidinyl]-1-piperazinyl}acetic acid)
Catalogue No.
1A19710
CAS No.
910297-53-9
Molecular Formula
C₂₂H₂₄ClN₇O₃S
Product Type
Pharmaceutical Analytical Impurities
View Details
DESBUTYNYL DESAMINOPYRIDINYL LINAGLIPTIN BROMIDE (25 mg) (8-Bromo-3,9-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-1H-purine-2,6-dione )
Catalogue No.
1A19870
CAS No.
2428491-17-0
Molecular Formula
C₁₆H₁₃BrN₆O₂
Product Type
Pharmaceutical Analytical Impurities
View Details
CITRACONIC ANHYDRIDE (100 mg) (3-Methylfuran-2,5-dione)
Catalogue No.
1800216
CAS No.
616-02-4
Molecular Formula
C₅H₄O₃
Product Type
Pharmaceutical Analytical Impurities
View Details
2-HYDROXYETHYL METHACRYLATE (100 mg) (2-Hydroxyethyl methacrylate )
Catalogue No.
1800171
CAS No.
868-77-9
Molecular Formula
C₆H₁₀O₃
Product Type
Pharmaceutical Analytical Impurities
View Details
5,6-DIHYDRO & 7,8-DIHYDRO CINACALCET RACEMATE HYDROCHLORIDE (25 mg) (Mixture of N-[1-(5,6-Dihydronaphthalen-1-yl)ethyl]-3-[3-(trifluoromethyl)phenyl]propan-1-amine hydrochloride and N-[1-(7,8-Dihydronaphthalen-1-yl)ethyl]-3-[3-(trifluoromethyl)phenyl]propan-1-amine hydrochloride)
Catalogue No.
1A17370
CAS No.
NA
Molecular Formula
C₂₂H₂₄F₃N.HCl
Product Type
Pharmaceutical Analytical Impurities
View Details
N-NITROSO APIXABAN OPEN RING AMIDE (25 mg) (6-(4-((5-Amino-5-oxopentyl)(nitroso)amino)phenyl)-1-(4-methoxyphenyl)-7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide )
Catalogue No.
1A13750
CAS No.
NA
Molecular Formula
C₂₅H₂₇N₇O₅
Product Type
Pharmaceutical Analytical Impurities
View Details

Got any Queries?

We value your curiosity and strive to provide you with all the information you need. If you have any questions or need further details about our products/services, company, or any other topic related to our website, feel free to reach out to us. Our team is here to assist you promptly.

Levonorgestrel Imp. G (EP)

Product Description

Product Description

Additional information

Related Products

Acebutolol Impurity D (EP)

Acebutolol Impurity D (EP)

Abiraterone Ethyl Ether

Abiraterone Ethyl Ether

Aceclofenac Impurity B (EP)

Aceclofenac Impurity B (EP)

Acamprosate Impurity C(EP)

Acamprosate Impurity C(EP)

Recently Viewed

RAC-LINAGLIPTIN (25 mg) (8-[3-Aminopiperidin-1-yl]-7-(but-2-yn-1-yl)-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]-3,7-dihydro-1H-purine-2,6-dione )

RAC-LINAGLIPTIN PIPERIDINYLAMINE (25 mg) (7-(2-Butyn-1-yl)-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-8-(3-piperidinylamino)-3,7-dihydro-1H-purine-2,6-dione )

N-FORMYL SITAGLIPTIN (25 mg) ((R)-N-(4-Oxo-4-{3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl}-1-(2,4,5-trifluorophenyl)butan-2-yl)formamide )

N-DEMETHYL EDOXABAN (25 mg) (N¹-(5-Chloropyridin-2-yl)-N²-((1S,2R,4S)-4-(dimethylcarbamoyl)-2-(4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine-2-carboxamido)cyclohexyl)oxalamide )

DASATINIB CARBOXYLIC ACID (25 mg) ({4-[6-({5-[(2-Chloro-6-methylphenyl)carbamoyl]-1,3-thiazol-2-yl}amino)-2-methyl-4-pyrimidinyl]-1-piperazinyl}acetic acid)

DESBUTYNYL DESAMINOPYRIDINYL LINAGLIPTIN BROMIDE (25 mg) (8-Bromo-3,9-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-1H-purine-2,6-dione )

CITRACONIC ANHYDRIDE (100 mg) (3-Methylfuran-2,5-dione)

2-HYDROXYETHYL METHACRYLATE (100 mg) (2-Hydroxyethyl methacrylate )

5,6-DIHYDRO & 7,8-DIHYDRO CINACALCET RACEMATE HYDROCHLORIDE (25 mg) (Mixture of N-[1-(5,6-Dihydronaphthalen-1-yl)ethyl]-3-[3-(trifluoromethyl)phenyl]propan-1-amine hydrochloride and N-[1-(7,8-Dihydronaphthalen-1-yl)ethyl]-3-[3-(trifluoromethyl)phenyl]propan-1-amine hydrochloride)

N-NITROSO APIXABAN OPEN RING AMIDE (25 mg) (6-(4-((5-Amino-5-oxopentyl)(nitroso)amino)phenyl)-1-(4-methoxyphenyl)-7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide )

Got any Queries?